Index Rebal Trades & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal Trades & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

Bengo4.com Inc offers lawyer and tax accountant advisory website services.

<ul>
<li>Quiddity's "Who is Ready" series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.</li>
<li>
<a href="https://www.smartkarma.com/entities/japan-eyewear-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:40217:1" rel="noopener">Japan Eyewear Holdings (5889 JP)</a>, <a href="https://www.smartkarma.com/entities/fit-easy-inc" target="_blank" data-smartkarma-citation="entities:45319:1" rel="noopener">FIT EASY (212A JP)</a>, and <a href="https://www.smartkarma.com/entities/tekscend-photomask-corp" target="_blank" data-smartkarma-citation="entities:45819:1" rel="noopener">Tekscend Photomask (429A JP)</a> were included in the TOPIX index at the end of November 2025.</li>
<li>
<a href="https://www.smartkarma.com/entities/bengo4-com-inc" target="_blank" data-smartkarma-citation="entities:20383:1" rel="noopener">Bengo4.Com Inc (6027 JP)</a> recently announced a Section Transfer to the Prime market which means there will be a TOPIX inclusion at the end of January 2026.</li>
</ul>


Quiddity's "Who is Ready" series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.

Japan Eyewear Holdings (5889 JP), FIT EASY (212A JP), and Tekscend Photomask (429A JP) were included in the TOPIX index at the end of November 2025.

Bengo4.Com Inc (6027 JP) recently announced a Section Transfer to the Prime market which means there will be a TOPIX inclusion at the end of January 2026.


TOPIX Inclusions: Who Is Ready (Dec 2025)

E.Sun Financial Holding Co / Index Rebalance

E.Sun Financial Holding Company Ltd. is a holding company.  Through its subsidiaries, the Company provides banking, brokerage and dealer services.

<ul>
<li>The index changes for the T50/100 index family and the TDIV index were confirmed after market close on Friday 5th December 2025.</li>
<li>There will be four ADD/DELs for T50, three separate ADDs/DELs for T100, and three ADDs/DELs for TDIV. </li>
<li>All of these changes were correctly predicted except for one surprise TDIV addition.</li>
</ul>


The index changes for the T50/100 index family and the TDIV index were confirmed after market close on Friday 5th December 2025.
There will be four ADD/DELs for T50, three separate ADDs/DELs for T100, and three ADDs/DELs for TDIV. 
All of these changes were correctly predicted except for one surprise TDIV addition.


Quiddity TDIV/50/100 Dec 25 Results: 19/20 Correctly Predicted; ~US$3bn Combined One-Way Flows

Resolute Mining Limited explores for, produces and develops gold in Mali and Queensland, Australia. The Company's gold exploration projects include Syama and Ravenswood.

<ul>
<li>The ADDs/DELs for the ASX index family for the December 2025 index rebal event were announced after market close on Friday 5th December 2025. </li>
<li>There are 20 ADDs and 20 DELs collectively for ASX 50, ASX 100, and ASX 200.  We got 19/20 predictions correct.</li>
<li>In this insight, we take a look at our final flow expectations for each of these confirmed index changes.</li>
</ul>


The ADDs/DELs for the ASX index family for the December 2025 index rebal event were announced after market close on Friday 5th December 2025. 
There are 20 ADDs and 20 DELs collectively for ASX 50, ASX 100, and ASX 200.  We got 19/20 predictions correct.
In this insight, we take a look at our final flow expectations for each of these confirmed index changes.


Quiddity ASX Dec25 Results: 19/20 Correctly Predicted; US$770mn Combined One-Way Flow; Avoid Crowds

Hebei Changshan Biochemical Pharm / Index Rebalance

Hebei Changshan Biochemical Pharmaceutical Company Limited is a state level biopharmaceutical company. The Company's main products include Heparin Sodium API (injection and non-injection), low molecular weight Heparin Calcium injection and Heparin Sodium injection.

Hebei Changshan Biochemical Pharm (300255 CH)

<ul>
<li>The June 2025 index review results for the ChiNext and ChiNext 50 indices were announced after market close on Friday 28th November 2025.</li>
<li>There will be eight changes for the ChiNext index and five changes for the ChiNext 50 index.</li>
<li>The ChiNext and ChiNext 50 index rebal events could trigger US$1.1bn and US$379mn in one-way flows respectively.</li>
</ul>


The June 2025 index review results for the ChiNext and ChiNext 50 indices were announced after market close on Friday 28th November 2025.
There will be eight changes for the ChiNext index and five changes for the ChiNext 50 index.
The ChiNext and ChiNext 50 index rebal events could trigger US$1.1bn and US$379mn in one-way flows respectively.


Quiddity ChiNext & ChiNext 50 Dec25 Results: ~US$1.5bn Combined One-Way Flow; Multiple Surprises

Zhenxing Biopharmaceutical & Chemicl / Index Rebalance

Zhenxing Biopharmaceutical and Chemical Co., Ltd manufactures and distributes biopharmaceutical and fine chemical products.  The Company also produces wheel forklift trucks and other accessories.

Zhenxing Biopharmaceutical & Chemicl (000403 CH)

<ul>
<li>The December 2025 index review results for China's CSI 1000 index were announced after market close on Friday 28th November 2025.</li>
<li>There will be 100 ADDs/DELs for CSI 1000 in the December 2025 rebalance.</li>
<li>The CSI 1000 index rebal event could trigger US$2.5bn in one-way flow.</li>
</ul>


The December 2025 index review results for China's CSI 1000 index were announced after market close on Friday 28th November 2025.
There will be 100 ADDs/DELs for CSI 1000 in the December 2025 rebalance.
The CSI 1000 index rebal event could trigger US$2.5bn in one-way flow.


Quiddity CSI 1000 Dec25 Results: 88% Hit Rate; 100 ADDs/DELs; ~US$2.5bn One-Way

Equity Analyst with 10+ years experience in fundamental and event-driven research.

On Smartkarma, I mainly publish insights on index flow events. This includes predicting regular and intra-review index changes and formulating market-neutral trading strategies based on flow catalysts. I also cover special situations such as mergers & acquisitions, equity offerings, buybacks, and other corporate restructuring events.